Williamson, Alice http://orcid.org/0000-0002-7599-9301
Norris, Dougall M.
Yin, Xianyong
Broadaway, K. Alaine
Moxley, Anne H.
Vadlamudi, Swarooparani
Wilson, Emma P.
Jackson, Anne U. http://orcid.org/0000-0002-9672-2547
Ahuja, Vasudha
Andersen, Mette K. http://orcid.org/0000-0001-8227-1469
Arzumanyan, Zorayr
Bonnycastle, Lori L.
Bornstein, Stefan R.
Bretschneider, Maxi P.
Buchanan, Thomas A. http://orcid.org/0000-0001-7892-5132
Chang, Yi-Cheng
Chuang, Lee-Ming http://orcid.org/0000-0003-0978-2662
Chung, Ren-Hua http://orcid.org/0000-0002-9835-6333
Clausen, Tine D.
Damm, Peter http://orcid.org/0000-0002-2067-5246
Delgado, Graciela E.
de Mello, Vanessa D.
Dupuis, Josée http://orcid.org/0000-0003-2871-3603
Dwivedi, Om P. http://orcid.org/0000-0001-8670-7717
Erdos, Michael R. http://orcid.org/0000-0002-6603-1833
Silva, Lilian Fernandes http://orcid.org/0000-0003-0225-842X
Frayling, Timothy M. http://orcid.org/0000-0001-8362-2603
Gieger, Christian http://orcid.org/0000-0001-6986-9554
Goodarzi, Mark O. http://orcid.org/0000-0001-6364-5103
Guo, Xiuqing http://orcid.org/0000-0002-5264-5068
Gustafsson, Stefan http://orcid.org/0000-0001-5894-0351
Hakaste, Liisa
Hammar, Ulf
Hatem, Gad
Herrmann, Sandra
Højlund, Kurt
Horn, Katrin http://orcid.org/0000-0002-5307-6936
Hsueh, Willa A.
Hung, Yi-Jen
Hwu, Chii-Min http://orcid.org/0000-0002-8209-9627
Jonsson, Anna
Kårhus, Line L.
Kleber, Marcus E. http://orcid.org/0000-0003-0663-7275
Kovacs, Peter http://orcid.org/0000-0002-0290-5423
Lakka, Timo A. http://orcid.org/0000-0002-9199-2871
Lauzon, Marie
Lee, I-Te
Lindgren, Cecilia M.
Lindström, Jaana
Linneberg, Allan http://orcid.org/0000-0002-0994-0184
Liu, Ching-Ti http://orcid.org/0000-0002-0703-0742
Luan, Jian’an http://orcid.org/0000-0003-3137-6337
Aly, Dina Mansour
Mathiesen, Elisabeth
Moissl, Angela P. http://orcid.org/0000-0003-0302-2136
Morris, Andrew P. http://orcid.org/0000-0002-6805-6014
Narisu, Narisu http://orcid.org/0000-0002-8483-1156
Perakakis, Nikolaos
Peters, Annette http://orcid.org/0000-0001-6645-0985
Prasad, Rashmi B. http://orcid.org/0000-0002-4400-6741
Rodionov, Roman N.
Roll, Kathryn
Rundsten, Carsten F.
Sarnowski, Chloé http://orcid.org/0000-0002-6090-7099
Savonen, Kai
Scholz, Markus http://orcid.org/0000-0002-4059-1779
Sharma, Sapna
Stinson, Sara E.
Suleman, Sufyan
Tan, Jingyi
Taylor, Kent D.
Uusitupa, Matti
Vistisen, Dorte
Witte, Daniel R.
Walther, Romy
Wu, Peitao
Xiang, Anny H.
Zethelius, Björn
de Mello, Vanessa D.
Ahlqvist, Emma http://orcid.org/0000-0002-6513-2384
Bergman, Richard N.
Chen, Yii-Der Ida
Collins, Francis S. http://orcid.org/0000-0002-1023-7410
Fall, Tove http://orcid.org/0000-0003-2071-5866
Florez, Jose C.
Fritsche, Andreas
Grallert, Harald
Groop, Leif http://orcid.org/0000-0002-0187-3263
Hansen, Torben http://orcid.org/0000-0001-8748-3831
Koistinen, Heikki A. http://orcid.org/0000-0001-7870-070X
Komulainen, Pirjo
Laakso, Markku http://orcid.org/0000-0002-3394-7749
Lind, Lars
Loeffler, Markus
März, Winfried
Meigs, James B.
Raffel, Leslie J.
Rauramaa, Rainer
Rotter, Jerome I.
Schwarz, Peter E. H. http://orcid.org/0000-0001-6317-7880
Stumvoll, Michael http://orcid.org/0000-0001-6225-8240
Sundström, Johan http://orcid.org/0000-0003-2247-8454
Tönjes, Anke
Tuomi, Tiinamaija http://orcid.org/0000-0002-8306-6202
Tuomilehto, Jaakko
Wagner, Robert http://orcid.org/0000-0002-6120-0191
Barroso, Inês http://orcid.org/0000-0001-5800-4520
Walker, Mark
Grarup, Niels http://orcid.org/0000-0001-5526-1070
Boehnke, Michael http://orcid.org/0000-0002-6442-7754
Wareham, Nicholas J. http://orcid.org/0000-0003-1422-2993
Mohlke, Karen L. http://orcid.org/0000-0001-6721-153X
Wheeler, Eleanor http://orcid.org/0000-0002-8616-6444
O’Rahilly, Stephen http://orcid.org/0000-0003-2199-4449
Fazakerley, Daniel J. http://orcid.org/0000-0001-8241-2903
Langenberg, Claudia http://orcid.org/0000-0002-5017-7344
,
Article History
Received: 4 August 2022
Accepted: 26 April 2023
First Online: 8 June 2023
Competing interests
: I.B. and spouse declare stock ownership in GlaxoSmithKline, Incyte Ltd. and Inivata Ltd. J.C.F. has received consulting honoraria from Goldfinch Bio and AstraZeneca; speaker honoraria from Novo Nordisk, AstraZeneca and Merck for research lectures over which he had full control on content. M.E.K. is employed by SYNLAB Holding Deutschland GmbH. C.L. receives grants from Bayer Ag & Novo Nordisk and her husband works for Vertex. W.M. reports grants and personal fees from Siemens Diagnostics, Aegerion Pharmaceuticals, AMGEN, AstraZeneca, Danone Research, Sanofi, Pfizer, BASF and Numares; personal fees from Hoffmann LaRoche, MSD, Synageva; grants from Abbott Diagnostics, outside the submitted work. W.M. is employed by Synlab Holding Deutschland GmbH. J.B.M. serves as an Academic Associate for Quest Diagnostics. S.O’R. has undertaken remunerated consultancy work for Pfizer, AstraZeneca, GSK and ERX Pharmaceuticals. N.P. reports consulting honoraria from Bayer Vital GmbH and speaker honoraria from Novo Nordisk. J.S. is shareholder in Anagram kommunikation AB and Symptoms Europe AB, outside of the present study. D.V. has received research grants from Bayer A/S, Sanofi, Novo Nordisk A/S and Boehringer Ingelheim and holds shares in Novo Nordisk A/S. E.W. is now an employee of AstraZeneca. B.Z. is employed at the Swedish Medical Products Agency, SE-751 03 Uppsala, Sweden. The views expressed in this paper are the personal views of the authors and not necessarily the views of the Swedish government agency. All other authors declare no competing interests.